CALCRL and acute myeloid leukemia: Recently, Sarah et al. identified a three-gene signature (CALCRL, CD109 and LSP1) predicts clinical outcomes’ prognostics in an AML research that accurately stratified survival, and exceeded the current ability of single molecule marker [6].